Finance

Lists
A1RE34:BVMF
Alexandria Real Estate Equities Inc Bdr
R$56,93
0,00%
(0,00) 1D
7 Okt., 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for A1RE34...
Open
R$57,18
High
R$57,19
Low
R$56,82
Mkt. cap
7,88 mjd
Avg. vol.
193,00
Volume
315,00
52-wk high
R$102,29
52-wk low
R$48,75
Shares outstanding
174,25 m
No. of employees
514
Open
R$57,18
High
R$57,19
Low
R$56,82
Mkt. cap
7,88 mjd
Avg. vol.
193,00
Volume
315,00
52-wk high
R$102,29
52-wk low
R$48,75
Shares outstanding
174,25 m
No. of employees
514
News stories
From web sources and news partners
Profile
Alexandria Real Estate Equities, Inc. is a real estate investment trust based in Pasadena, California that invests in office buildings and laboratories leased to tenants in the life science and technology industries. Properties are generally located near universities to attract tenants. The company owns several major technology/biotechnology office campuses including the 740,972 square foot Alexandria Center for Life Science in Manhattan, and the 2,365,487 square foot Alexandria Center at Kendall Square and the 1,181,635 square foot Technology Square in the Boston area. The company is dependent on the life sciences industry and funding for research by the United States Government. The company also has a venture capital arm, Alexandria Venture Investments, which invests in life sciences firms. The company is named after Alexandria, Egypt because of that city's connection to science. Wikipedia
About Alexandria Real Estate Equities Inc Bdr
CEOPeter M. Moglia
Employees514
Founded01 Jan. 1994
HeadquartersPasadena, Kalifornië, Verenigde State van Amerika
SectorReal estate investment trust
Websiteare.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
752,14 m
754,11 m
670,88 m
663,20 m
Cost of goods sold
239,23 m
232,54 m
224,14 m
207,34 m
Cost of revenue
239,23 m
232,54 m
224,14 m
207,34 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29,22 m
28,02 m
34,68 m
36,86 m
Operating expense
369,45 m
350,08 m
340,13 m
341,24 m
Total operating expenses
608,69 m
582,63 m
564,27 m
548,58 m
Operating income
143,46 m
171,48 m
106,61 m
114,62 m
Other non operating income
-
-
-
-
EBT including unusual items
-197,84 m
-995,35 m
398,38 m
-38,97 m
EBT excluding unusual items
116,77 m
105,81 m
37,44 m
183,50 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-232,75 m
-1,08 mjd
361,65 m
-72,78 m
Net profit margin
-30,95%
-143,33%
53,91%
-10,97%
Earnings per share
0,50
-
-
0,15
Interest and investment income
28,16 m
-
-
133,23 m
Interest expense
-54,85 m
-65,67 m
-69,17 m
-64,34 m
Net interest expenses
-26,69 m
-65,67 m
-69,17 m
68,88 m
Depreciation and amortization charges
340,23 m
322,06 m
305,44 m
304,38 m
EBITDA
477,23 m
487,66 m
406,43 m
410,62 m
Gain or loss from assets sale
-9,37 m
-619,91 m
-
-
AI content may include mistakes. Learn more
Google-programme